Researchers at the University of Gothenburg and the Institute of Biomedical Investigation of Girona have found that gut microbial shifts under metformin treatment contribute to improved blood sugar control.
They believe that the drug effects on blood glucose may result from normalising the dysbiosis or imbalance of the gut flora that has been previously linked with type 2 diabetes.
Earlier research has found that metformin is distinctly different from other types of diabetes medication in that it caused profound changes in the gut microbiome of users.
In the new findings, published in the journal Nature Medicine, the authors suggest that these differences may influence both metformin’s efficacy and side effects.
Read At: Diabetes.co.uk